Abstract
We have previously proposed a staging system for large cell lymphoma using the two serum markers beta-2-microglobulin (B2M) and lactate dehydrogenase (LDH). We recently tested this model in a different cohort of patients with large cell lymphoma and also examined the possible contribution of thymidine kinase (TK), a previously reported serologic prognostic factor. Using an inclusion criteria in the multivariate analysis for both forward and backward selection of p < 0.15, only LDH, B2M, and TK were significant independent prognostic factors for both time to treatment failure (TTF) and survival. Inclusion of TK in the serologic model resulted in three significantly different risk groups for both TTF and survival. Corresponding endpoints at three years were: 1) good risk (no markers elevated, n = 43): 78%, 91%; 2) intermediate risk (1 or 2 markers elevated, n = 47): 41%, 36%; 3) poor risk (3 markers elevated, n = 11): 0%, 0%. This analysis extends the observation of the independent prognostic significance of B2M and LDH. The addition of TK permits a more precise estimate of risk, contributing to the utility of a serological staging system for large cell lymphoma.
References
Jan 1, 1979·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·S Kit
May 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P L Amlot, M Adinolfi
Nov 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RodríguezJ Romaguera
Jul 1, 1992·Annals of Hematology·M HallekB Emmerich
Feb 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B CoiffierJ O Armitage
Jan 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S E O'ReillyJ M Connors
May 1, 1991·Hematological Oncology·G RossiT Izzi
Jun 1, 1986·Annals of Internal Medicine·M A ShippG P Canellos
Jun 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S JagannathF C Cabanillas
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B CoiffierN Brousse
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesJ M Connors
Oct 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F SwanF Cabanillas
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Feb 1, 1989·British Journal of Cancer·R A CowanD Crowther
Aug 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C GulatiI Cunningham
Aug 15, 1988·Klinische Wochenschrift·M HallekR Senekowitsch
Mar 1, 1988·International Journal of Radiation Oncology, Biology, Physics·M ChadhaS Gulati
Apr 1, 1988·European Journal of Haematology·U MartinssonC Sundström
Jan 1, 1987·Journal of Medical Genetics·P Tsipouras, F Ramirez
Oct 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D O DixonE A Gehan
Jan 1, 1985·Leukemia Research·H G DrexlerJ Minowada
Oct 1, 1985·British Journal of Haematology·B SimonssonJ S Gronowitz
Aug 1, 1985·European Journal of Cancer & Clinical Oncology·P VezzoniF Rilke
Dec 1, 1974·Experimental Cell Research·L J Bello
Jun 15, 1983·Cancer·H HagbergB Simonsson
Jul 1, 1984·Scandinavian Journal of Haematology·H HagbergT Schröder
Jun 15, 1984·Cancer·B KozinerB J Lee
Jul 1, 1984·European Journal of Cancer & Clinical Oncology·W P StewardD Crowther
Nov 1, 1982·Cancer·J O ArmitageD J Slymen
Apr 1, 1983·British Journal of Cancer·J S GronowitzB Simonsson
Citations
Mar 1, 2012·Annals of Hematology·Zhi-Ming LiWen-Qi Jiang
Jul 25, 2009·International Journal of Hematology·Wei XuJian-Yong Li
Feb 9, 2010·Journal of Cancer Research and Clinical Oncology·Zhu-Lin PanSven Skog
Mar 16, 2013·Leukemia & Lymphoma·Kazuhito SuzukiKiyohiko Hatake
Feb 1, 2011·Leukemia & Lymphoma·Mary J NinanPankaj Gupta
Feb 1, 2008·Expert Opinion on Medical Diagnostics·Ondrej Topolcan, Lubos Holubec
Nov 3, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Taner KorkmazN Serdar Turhal
Mar 6, 2012·American Journal of Hematology·Ji-Won KimByoung Kook Kim
Jan 13, 2012·Veterinary and Comparative Oncology·D H ThammK A Selting
May 15, 2003·Hematology·S ArefK Zalata
Jul 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Di RaimondoM J Keating
May 18, 2021·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Gordon J RuanThomas E Witzig